Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months

NCT00311428 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influenza

Sponsor

Novartis

Collaborators

[object Object]